Connect with us

archive

Welcome to the Big Leagues, Big Pharma

Welcome to the Big Leagues, Big Pharma (Bloomberg)

In a deal akin to the Boston Red Sox swapping players with the New York Yankees and Los Angeles Dodgers at the same time, three of the biggest “Big Pharmas” have agreed to a whopper of a deal. Novartis AG (NOVN) seems intent on reinventing itself, as the company has agreed to buy GlaxoSmithKline Plc’s (GSK) entire line of cancer drug assets for as much as $16 billion. In return, NOVN will sell its vaccine business (excluding flu assets) to GSK for $7.1 billion. NOVN has also agreed to sell its animal health operation to Eli Lilly & Co. (LLY) for an additional $5.4 billion. Who knows how this Big Pharma three-way will reshape share prices for Novartis, Glaxo or Eli Lilly? Our guess? One of the three will make out like a bandit.

Newsletter Signup.

Sign up to the Human Events newsletter

Advertisement
Advertisement

TRENDING NOW:

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

Al Jazeera: ‘Jews Exploit Holocaust’.

FOREIGN AFFAIRS

‘Reaganesque’: Economist Tells CNBC Trump Could Shift Global Order In China Trade War

FOREIGN AFFAIRS

Salvini: ‘Extremists’ Are Those Who’ve Governed Europe in the Name of Finance, Multinationalism, Mass Migration.

FOREIGN AFFAIRS

archive

Welcome to the Big Leagues, Big Pharma

Three of the biggest â??Big Pharmasâ? have agreed to a whopper of a deal.

Welcome to the Big Leagues, Big Pharma (Bloomberg)

In a deal akin to the Boston Red Sox swapping players with the New York Yankees and Los Angeles Dodgers at the same time, three of the biggest â??Big Pharmasâ? have agreed to a whopper of a deal. Novartis AG (NOVN) seems intent on reinventing itself, as the company has agreed to buy GlaxoSmithKline Plcâ??s (GSK) entire line of cancer drug assets for as much as $16 billion. In return, NOVN will sell its vaccine business (excluding flu assets) to GSK for $7.1 billion. NOVN has also agreed to sell its animal health operation to Eli Lilly & Co. (LLY) for an additional $5.4 billion. Who knows how this Big Pharma three-way will reshape share prices for Novartis, Glaxo or Eli Lilly? Our guess? One of the three will make out like a bandit.

Newsletter Signup.

Sign up to the Human Events newsletter

Written By

TRENDING NOW:

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

Al Jazeera: ‘Jews Exploit Holocaust’.

FOREIGN AFFAIRS

‘Reaganesque’: Economist Tells CNBC Trump Could Shift Global Order In China Trade War

FOREIGN AFFAIRS

Salvini: ‘Extremists’ Are Those Who’ve Governed Europe in the Name of Finance, Multinationalism, Mass Migration.

FOREIGN AFFAIRS

Connect
Newsletter Signup.

Sign up to the Human Events newsletter